Yang DR - Search Results

1

TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.

Lin SJ, Yang DR, Li G, Chang C. Lin SJ, et al. Among authors: yang dr. Front Endocrinol (Lausanne). 2015 May 27;6:78. doi: 10.3389/fendo.2015.00078. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26074876 Free PMC article. Review.

2

Higher expression of peroxisome proliferator-activated receptor γ or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion.

Yang DR, Lin SJ, Ding XF, Miyamoto H, Messing E, Li LQ, Wang N, Chang C. Yang DR, et al. Urology. 2013 May;81(5):1109.e1-6. doi: 10.1016/j.urology.2012.12.027. Epub 2013 Mar 19. Urology. 2013. PMID: 23522297

3

Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.

Yang DR, Ding XF, Luo J, Shan YX, Wang R, Lin SJ, Li G, Huang CK, Zhu J, Chen Y, Lee SO, Chang C. Yang DR, et al. J Biol Chem. 2013 Jun 7;288(23):16476-16483. doi: 10.1074/jbc.M112.448142. Epub 2013 Apr 22. J Biol Chem. 2013. PMID: 23609451 Free PMC article.

4

TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.

Lin SJ, Lee SO, Lee YF, Miyamoto H, Yang DR, Li G, Chang C. Lin SJ, et al. Among authors: yang dr. Carcinogenesis. 2014 Jun;35(6):1399-406. doi: 10.1093/carcin/bgu052. Epub 2014 Feb 28. Carcinogenesis. 2014. PMID: 24583925 Free PMC article.

5

Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.

Liu S, Lin SJ, Li G, Kim E, Chen YT, Yang DR, Tan MH, Yong EL, Chang C. Liu S, et al. Among authors: yang dr. Endocr Relat Cancer. 2014 Jun;21(3):R279-300. doi: 10.1530/ERC-13-0529. Epub 2014 Mar 12. Endocr Relat Cancer. 2014. PMID: 24623743 Review.

6

Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4.

Lin SJ, Zhang Y, Liu NC, Yang DR, Li G, Chang C. Lin SJ, et al. Among authors: yang dr. Mol Endocrinol. 2014 Jun;28(6):805-21. doi: 10.1210/me.2013-1422. Epub 2014 Apr 4. Mol Endocrinol. 2014. PMID: 24702179 Free PMC article.

7

TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.

Ding X, Yang DR, Lee SO, Chen YL, Xia L, Lin SJ, Yu S, Niu YJ, Li G, Chang C. Ding X, et al. Among authors: yang dr. Int J Cancer. 2015 Feb 15;136(4):955-64. doi: 10.1002/ijc.29049. Epub 2014 Jul 14. Int J Cancer. 2015. PMID: 24975468 Free article.

8

Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.

Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, Wang M, Li G, Chang C. Ding X, et al. Among authors: yang dr. Mol Cancer. 2015 Jan 27;14(1):16. doi: 10.1186/s12943-014-0281-1. Mol Cancer. 2015. PMID: 25623427 Free PMC article.

9

TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.

Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, Shan Y, Chang C. Zhu J, et al. Among authors: yang dr. Mol Cancer Ther. 2015 Jun;14(6):1445-53. doi: 10.1158/1535-7163.MCT-14-0971. Epub 2015 Apr 1. Mol Cancer Ther. 2015. PMID: 25833838 Free PMC article.

10

TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.

Lin SJ, Yang DR, Wang N, Jiang M, Miyamoto H, Li G, Chang C. Lin SJ, et al. Among authors: yang dr. Oncoscience. 2015 Feb 9;2(2):142-50. doi: 10.18632/oncoscience.121. eCollection 2015. Oncoscience. 2015. PMID: 25859557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page